Scribe Therapeutics Inc. (SCTX)

Scribe Therapeutics will go public soon, but the exact IPO date is still unknown.

Stock Price: Pending

IPO price not available yet

Scribe Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Debt / Equity Ratio	-0.29	-0.29	-0.33
Debt / EBITDA Ratio	-1.38	-2.01	-1.10
Debt / FCF Ratio	-1.16	-0.89	-0.89
Net Debt / Equity Ratio	0.02	0.12	0.50
Net Debt / EBITDA Ratio	0.10	0.80	1.68
Net Debt / FCF Ratio	0.09	0.36	1.36
Quick Ratio	0.64	0.94	3.09
Return on Equity (ROE)	22.51%	15.21%	37.97%
Return on Assets (ROA)	-	-27.88%	-37.34%
Return on Invested Capital (ROIC)	-	-51.06%	-46.08%
Return on Capital Employed (ROCE)	46.88%	-267.88%	-44.47%